期刊文献+

抗真菌药物靶标及其抑制剂的研究进展 被引量:2

Progress on antifungal drug targets and inhibitors
下载PDF
导出
摘要 目的综述抗真菌药物靶标及其抑制剂的研究进展。方法本文结合自身研究工作,分析近5年文献,总结抗真菌药物靶标及其抑制剂的最新进展。结果β-1,3-葡聚糖合成酶、羊毛甾醇14α-去甲基化酶、N-肉豆蔻酰基转移酶和分泌型天冬氨酸蛋白酶是目前研究最为集中的抗真菌药靶,其抑制剂显示了良好的新药开发前景。结论优化现有药物化学结构和发现全新作用机制的先导化合物,对研发新一代抗真菌药物具有重要意义。 Objective To review recent progress of antifungal drug targets and their inhibitors. Methods Literatures in re- cent five years were analyzed in combination of the authors'own research work and recent developments of antifungal targets and inhibi- tors were summarized. Results Current research focused on lanosterol 14-demethylase, β-1,3-gluean synthasc, N-myristoyltransferase and secreted aspartic protease. The inhibitors of these targets showed promising future for the development of new antifungal drugs. Conclusion Optimizing the chemical structures of current antifungal agents and discover lead compounds with novel mode of action are of great importance to develop new generation of antifungal agents.
出处 《药学实践杂志》 CAS 2013年第5期321-325,379,共6页 Journal of Pharmaceutical Practice
基金 国家自然科学基金重点项目(30930107)
关键词 抗真菌药物靶标 β-1 3-葡聚糖合成酶 羊毛甾醇14α-去甲基化酶 N-肉豆蔻酰基转移酶 分泌型天冬氨酸蛋白酶 antifungal drug targets lanosterol 14-demethylase β-1 , 3-glucan synthase N-myristoyhransferase Secreted aspar- tic protease
  • 相关文献

参考文献29

  • 1Brown GD, Denning DW, Levitz SM. Tackling human fungal in?fections[J] . Science ,2012,336 (6082) :647.
  • 2Lai CC, Tan CK, Huang YT ,et al. Current challenges in the man?agement of invasive fungal infections[J] .J Infect Chemother, 2008 , 14 ( 2) : 77 .
  • 3Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with mv / AIDS[J] . AIDS. 2009, 23 ( 4 ) :525.
  • 4Sheng C ,Zhang W. New lead structures in antifungal drug discov?ery[J]. Curr Med Chern. 2011 ,18(5): 733.
  • 5LiuJ, Balasubramanian MK. I, 3-beta-Glucan synthase: a useful target for antifungal drugs[J] . Curr Drug Targets Infect Disord. 2001,1(2) :159.
  • 6Kondoh 0, Inagaki Y, Fukuda H, et al. Piperazine propanol de?rivative as a novel antifungal targeting I, 3-beta-D-glucan syn?thaseJ J}. Bioi Pharrn Bull, 2005 ,28( II) :2138.
  • 7Ting PC, Kuang R , W u H, et al. The synthesis and structure-activ?ity relationship of pyridazinones as glue an synthase inhibitors[J]. Bioorg Med Chern Lett. 2011,21 (6) : 1819.
  • 8Zhou G, Ting PC, Aslanian R, et al. SAR studies of pyridazinone derivatives as novel glue an synthase inhibitors[J]. Bioorg Med Cbem Lett. 2011,21 (10) :2890.
  • 9GuineaJ , Recio S, Escribano P, et al. In vitro antifungal activities of isavuconazole and comparators against rare yeast pathogens[J). Antimicrob Agents Chemother. 2010 ,54 (9) :4012.
  • 10MillerJL, Schell W A, Wills EA, et al. In vitro and in vivo effica?cies of the new triazole alhaconazole against Cryptococcus neofor- mans[J]. Antimicrob Agents Chemother ,2004,48 (2) :384.

同被引文献5

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部